Page 1 of Clinical Trials for Leiomyosarcoma, 111 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Last Updated: January 25, 2012
Condition(s): Uterine Leiomyosarcoma; Uterine Cancer
2
Active, not recruiting
Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Last Updated: October 25, 2011
Condition(s): Leiomyosarcoma; Uterine Neoplasm
3
Active, not recruiting
Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Last Updated: October 25, 2011
Condition(s): Leiomyosarcoma
4
Completed
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Last Updated: January 26, 2012
Condition(s): Leiomyosarcoma; Uterine Neoplasm
5
Recruiting
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Last Updated: May 18, 2012
Condition(s): Advanced Liposarcoma or Leiomyosarcoma
6
Recruiting
Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
Last Updated: November 29, 2011
Condition(s): Leiomyosarcoma; Liposarcoma
7
Recruiting
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Last Updated: December 13, 2009
Condition(s): Sarcoma
8
Completed
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Last Updated: December 13, 2009
Condition(s): Ovarian Cancer; Sarcoma; Small Intestine Cancer
9
Active, not recruiting
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Last Updated: July 23, 2008
Condition(s): Sarcoma
10
Not yet recruiting
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Last Updated: April 24, 2012
Condition(s): Sarcoma
11
Recruiting
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Last Updated: May 22, 2012
Condition(s): Sarcoma
12
Not yet recruiting
Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas
Last Updated: September 27, 2011
Condition(s): Leiomyosarcoma
13
Completed
Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Last Updated: March 3, 2010
Condition(s): Sarcoma
14
Recruiting
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Last Updated: March 17, 2012
Condition(s): Sarcoma
15
Completed
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Last Updated: February 13, 2009
Condition(s): Sarcoma
16
Suspended
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
Last Updated: April 14, 2009
Condition(s): Sarcoma
17
Completed
A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma
Last Updated: May 8, 2012
Condition(s): Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET); Rhabdomyosarcoma; Leiomyosarcoma; Adipocytic Sarcoma; Synovial Sarcoma
18
Completed
Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
Last Updated: April 28, 2009
Condition(s): Cancer
19
Completed
A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer
Last Updated: April 5, 2012
Condition(s): Liposarcoma; Leiomyosarcoma; Neoplasms, Connective and Soft Tissue; Neoplasms, Adipose Tissue; Neoplasms, Muscle Tissue; Neoplasms by Histologic Type; Sarcoma
20
Recruiting
HLA-Matched Allogeneic Cytotoxic T Lymphocytes (CTLs) for Treatment of Patients With Relapsed Epstein Barr Virus (EBV)-Associated Diseases
Last Updated: April 11, 2012
Condition(s): Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Lymphoproliferative Disorder; Nasopharyngeal Carcinoma; Leiomyosarcoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Leiomyosarcoma

Page 1 of Clinical Trials for Leiomyosarcoma, 111 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About